CYFRA 21-1 As a Predictor to Response to Chemotherapy and Overall Survival in Patients with Advanced NSCLC

被引：0
|
作者：
Lqbal, K. [1 ]
机构：
[1] Oncol & Radiotherapy Inst, Oncol Nucl Med, Islamabad, Pakistan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
CYFRA; 21-1; ADVANCED NSCLC; OVERALL SURVIVAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-44
引用
收藏
页码：S884 / S884
页数：1
相关论文
共 50 条
  • [21] Combined Use of CYFRA 21-1, CA125 and CRP Predicts Survival of Metastatic NSCLC Patients With Stable Disease
    Mang, A.
    Zou, W.
    Rolny, V.
    Reck, M.
    Cigoianu, D.
    Schulze, K.
    Mazumder, A.
    Socinski, M.
    Shames, D.
    Morgenstern, D.
    Wehnl, B.
    Patil, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1024 - S1025
  • [22] Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream
    Helga Sertić Milić
    Ana Franjević
    Gordana Bubanović
    Ante Marušić
    Igor Nikolić
    Igor Puljić
    Wiener klinische Wochenschrift, 2015, 127 : 465 - 471
  • [23] Serum tumor marker CYFRA 21-1 in the diagnostics of NSCLC lung cancer
    Pavicevic, R
    Milicic, J
    Bubanovic, G
    Supe, S
    COLLEGIUM ANTROPOLOGICUM, 1998, 22 (02) : 629 - 635
  • [24] CEA and CYFRA 21-1 as Prognostic Biomarkers of Benefit from Nivolumab and as a Tool in Treatment Monitoring in Advanced NSCLC
    Dall'Olio, F. G.
    Abbati, F.
    Facchinetti, F.
    Gelsomino, F.
    Melotti, B.
    Massucci, M.
    Buti, S.
    Veneziani, M.
    Tiseo, M.
    Ardizzoni, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S257 - S257
  • [25] Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream
    Milic, Helga Sertic
    Franjevic, Ana
    Bubanovic, Gordana
    Marusic, Ante
    Nikolic, Igor
    Puljic, Igor
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (11-12) : 465 - 471
  • [26] CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients
    Muley, T
    Dienemann, H
    Ebert, W
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1953 - 1956
  • [27] The importance of the tumor marker CYFRA 21-1 in patients with lung cancer after surgery or chemotherapy
    Zisimopoulos, Athanasios
    Stellos, Konstantinos
    Permenopoulou, Vanesa
    Petrakis, Georgios
    Theodorakopoulos, Panagiotis
    Baziotis, Nikolaos
    Thalassinos, Nikolaos
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2007, 10 (01): : 62 - 66
  • [28] CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer An observational study
    Zhao, Tongwei
    Jin, Ying
    Mao, Guangyun
    Wei, Yaping
    Wu, Guoqing
    Ye, Xiao
    Zhou, Yonglie
    Yuan, Guorong
    Gao, Liang
    Hong, Yupeng
    Chen, Yun
    Hong, Chaojin
    Zhou, Hongying
    Su, Dan
    Qin, Zhiquan
    Lu, Liqin
    MEDICINE, 2016, 95 (52)
  • [29] CYFRA 21-1: An indicator of survival and therapeutic effect in lung cancer
    Takei, Y
    Minato, K
    Tsuchiya, S
    Takise, A
    Nakano, H
    Ezawa, K
    Fueki, N
    Hoshino, H
    Naruse, I
    Nomoto, T
    Makimoto, T
    Ishihara, S
    Saito, R
    Mori, M
    ONCOLOGY, 1997, 54 (01) : 43 - 47
  • [30] PROGNOSTIC IMPACT OF SERUM CYFRA 21-1 IN ADVANCED LUNG ADENOCARCINOMA
    Ono, A.
    Takahashi, T.
    Akamatsu, H.
    Taira, T.
    Shukuya, T.
    Kenmotsu, H.
    Naito, T.
    Murakami, H.
    Endo, M.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 430 - 430
12345